Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,540 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reasons for lesion uncrossability as assessed by intravascular ultrasound.
Salem H, Mintz GS, Matsumura M, Zhang M, Usui E, Seike F, Fujimura T, Noguchi M, Hu X, Jin G, Li C, Fall KN, Ali ZA, Kirtane AJ, Collins MB, Kodali SK, Nazif TM, Leon MB, Moses JW, Karmpaliotis D, Maehara A. Salem H, et al. Among authors: jin g. Catheter Cardiovasc Interv. 2022 Jun;99(7):2028-2037. doi: 10.1002/ccd.30202. Epub 2022 Apr 14. Catheter Cardiovasc Interv. 2022. PMID: 35419936
Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis.
Chen Z, Matsumura M, Mintz GS, Noguchi M, Fujimura T, Usui E, Seike F, Hu X, Jin G, Li C, Salem H, Fall KN, Shlofmitz E, Kirtane AJ, Cao JJ, Moses JW, Ali ZA, Jeremias A, Shlofmitz RA, Maehara A. Chen Z, et al. Among authors: jin g. Circ Cardiovasc Interv. 2022 Sep;15(9):e011693. doi: 10.1161/CIRCINTERVENTIONS.121.011693. Epub 2022 Sep 20. Circ Cardiovasc Interv. 2022. PMID: 36126137
Impact of Nonobstructive Left Main Coronary Artery Atherosclerosis on Long-Term Mortality.
Noguchi M, Gkargkoulas F, Matsumura M, Kotinkaduwa LN, Hu X, Usui E, Fujimura T, Seike F, Salem H, Jin G, Li C, Yamamoto K, Sato T, Redfors B, Fall KN, Nazif TM, Ali ZA, Karmpaliotis D, Parikh SA, Weisz G, Collins MB, Privitera LT, Rabbani LE, Leon MB, Moses JW, Stone GW, Kirtane AJ, Mintz GS, Maehara A. Noguchi M, et al. Among authors: jin g. JACC Cardiovasc Interv. 2022 Nov 14;15(21):2206-2217. doi: 10.1016/j.jcin.2022.08.024. Epub 2022 Oct 12. JACC Cardiovasc Interv. 2022. PMID: 36357025 Free article.
Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial.
Shi Y, Cui D, Xia L, Shi D, Jin G, Wang S, Lin Y, Tang X, Chi J, Wang T, Li M, Lv Z, Zheng J, Jia Q, Yang W, Sun Z, Yang F, Feng H, Yuan S, Zhou W, Qin W, Bernards R, Jin H, Zhai B. Shi Y, et al. Among authors: jin g. Signal Transduct Target Ther. 2024 Dec 9;9(1):359. doi: 10.1038/s41392-024-02085-8. Signal Transduct Target Ther. 2024. PMID: 39653700 Free article. Clinical Trial.
Colorectal cancer screening based on fecal immunochemical test and risk assessment: a population-based study including two million participants in China.
Hang D, Zhu C, Yang X, He J, Li H, Pan T, Wang L, Wang S, Wu W, Zhong J, Gong W, Zhu M, Song C, Ma H, Li N, Qiu Y, Jin G, Hu Z, Du L, Cheng X, Shen H. Hang D, et al. Among authors: jin g. J Epidemiol. 2024 Dec 7. doi: 10.2188/jea.JE20240252. Online ahead of print. J Epidemiol. 2024. PMID: 39647912 Free article.
4,540 results